15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 20 firms covering Insulet Corporation, 17 rate it Buy or better, 2 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets range widely, $172.00 to $360.00 (about 2.1x), a sign of real disagreement on valuation. The average target of $232.44 sits 39% above the current $167.49. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 16 to 17 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.63 next quarter toward $8.05 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS20 ratings
Moderate Buy
Strong Buy00%
Buy1785%
Hold210%
Sell15%
Strong Sell00%
Based on 20 analysts giving stock ratings to Insulet Corporation.
As of Jul, 17 of 20 firms rate PODD a Buy (2 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
PODD EPS & revenue forecast
EPS · NEXT QUARTER
$1.63
Range $1.54 – $1.71 · 20 analysts · +32% YoY
Next period, 20 analysts expect Insulet Corporation to earn $1.63 a share (range $1.54 – $1.71), versus $1.24 a year earlier. Full-year consensus is $6.48, growing to $8.05 the year after.
REVENUE · NEXT QUARTER
$844.9M
Range $829.8M – $853.3M · 20 analysts · +20% YoY
Revenue is expected to reach $844.9M (range $829.8M – $853.3M), +19.6% year-over-year. Full-year consensus is $3.3B, rising to $3.9B next year.
Top analysts covering Insulet Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PODD.
#1
Jonathan Block
Stifel · Rank #172
Buy
$225.00+34.3% to target
Overall win rate
42%
+ Follow
#2
William Plovanic
Canaccord Genuity · Rank #190
Buy
$249.00+48.7% to target
Overall win rate
36%
+ Follow
#3
Bruce Jackson
Benchmark · Rank #317
Buy
$250.00+49.3% to target
Overall win rate
35%
+ Follow
#4
Richard Newitter
Truist Securities
Buy
$210.00+25.4% to target
Coverage
—
+ Follow
#5
Joanne Wuensch
Citigroup
Hold
$172.00+2.7% to target
Coverage
—
+ Follow
PODD stock forecast FAQ
What is PODD's average 12-month price target?+
The 16 analysts with a live target average $232.44 for Insulet Corporation over the next 12 months, ranging from a $360.00 high to a $172.00 low.
Is PODD stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 20 analyst ratings, 17 are Buy or Strong Buy, 2 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for PODD?+
The Street-high target is $360.00 (Leerink Partners), and the Street-low is $172.00 (Citigroup). The average of all 16 active targets is $232.44.
How many Wall Street analysts cover PODD?+
20 analysts have an active rating on Insulet Corporation, and 16 firms carry a live 12-month price target.
Who is the most accurate analyst covering PODD?+
Among analysts who currently cover PODD, Jonathan Block of Stifel has the strongest overall Quantellect track record (Rank #172). Their current call is Buy with a $225.00 target.
What is Insulet Corporation's projected EPS for next quarter?+
The consensus estimate is $1.63 per share (range $1.54 – $1.71) across 20 analysts. Full-year EPS is projected at $6.48, rising to $8.05 the following year.
How much revenue is Insulet Corporation expected to report next quarter?+
Consensus revenue is $844.9M (range $829.8M – $853.3M). Full-year revenue is projected at $3.3B, growing to $3.9B next year.
Have analysts been upgrading or downgrading PODD lately?+
As of Jul, 17 of 20 firms rate PODD a Buy (2 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PODD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
